Market Performance - On the first trading day of 2026, A-shares experienced a positive start with all three major indices rising. The Shanghai Composite Index closed at 4023.42, up 1.38%, the Shenzhen Component Index at 13828.63, up 2.24%, and the ChiNext Index at 3294.55, up 2.85%. The total market turnover reached 25,672 billion yuan, with over 4,100 stocks rising [1]. Sector Highlights - The brain-computer interface sector led the gains, with stocks like Beiyikang hitting the daily limit of 30% increase. Other notable performers included Botai Biology, Daoshi Technology, Sanbo Brain Science, Aipeng Medical, and Dinake, which saw 20% increases. The innovative drug concept stocks also surged, with Guanhao Biology reaching a 20% limit up, alongside Selly Medical, Zhaoyan New Drug, and Kanghong Pharmaceutical [2]. - The insurance sector saw significant gains, with Xinhua Insurance rising over 8% and China Pacific Insurance up over 7%. The commercial aerospace sector also performed well, with stocks like Puni Testing, Yunhan Chip City, Danghong Technology, and Xice Testing hitting 20% limits [2]. Economic Outlook - The chief economist of Qianhai Open Source Fund, Yang Delong, believes that technology stocks will remain a key theme throughout 2025 and that the technology bull market is likely to continue into 2026. This optimism is attributed to China's economic transition and the focus on technological innovation in the 14th Five-Year Plan, which is expected to attract significant capital inflow [2]. - Yang Delong also noted that the logic supporting the current bull market remains unchanged, including policy support, a significant shift in household savings, and breakthroughs in technological innovation that have boosted foreign confidence in the Chinese economy. Additionally, the ongoing interest rate cuts by the Federal Reserve and the depreciation of the US dollar are expected to attract more foreign capital into RMB assets, leading to asset value reassessment [2]. Seasonal Trends - The A-share market typically experiences a "spring offensive," with January often seeing the highest credit issuance of the year, generally between 30,000 to 40,000 billion yuan, which helps channel funds into the capital market. The first quarter is also a period of low earnings disclosures for listed companies, favoring investments in technology sectors with potential themes and valuation elasticity [3]. - The spring market has already begun, with the index continuing its upward trend. Yang Delong advises investors to maintain confidence and patience. Galaxy Securities also highlighted that the performance of the Hong Kong stock market and the strengthening of the RMB during the holiday period could boost investor confidence, suggesting that the A-share market may continue its structural trend [3].

Core Viewpoint - The A-share market opened positively on the first trading day of 2026, with all three major indices rising, indicating strong investor sentiment and market momentum [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4023.42, up 1.38% - The Shenzhen Component Index closed at 13828.63, up 2.24% - The ChiNext Index closed at 3294.55, up 2.85% - Total market turnover reached 25,672 billion, with over 4,100 stocks rising [1]. Group 2: Sector Performance - The brain-computer interface sector led the gains, with stocks like Beiyikang hitting the daily limit, and several others such as Botao Biology and Daoshi Technology also reaching significant increases [2]. - Innovative drug concept stocks saw collective gains, with stocks like Guanhao Biology and Seli Medical hitting the daily limit [2]. - The insurance sector performed well, with Xinhua Insurance rising over 8% and China Pacific Insurance up over 7% [2]. - The commercial aerospace sector also showed strong performance, with multiple stocks reaching the daily limit [2]. Group 3: Economic Outlook - The chief economist of Qianhai Kaiyuan Fund, Yang Delong, believes that technology stocks will continue to be a main theme in 2026, driven by China's economic transformation and the focus on technological innovation in the 14th Five-Year Plan [2]. - The ongoing support for the bull market includes policy backing, a significant shift in household savings, and breakthroughs in technological innovation, which have boosted foreign confidence in the Chinese economy [2]. - The Federal Reserve's ongoing interest rate cuts and the depreciation of the US dollar are expected to attract more foreign capital into RMB assets, leading to asset value reassessment [2]. Group 4: Seasonal Trends - The A-share market typically experiences a "spring offensive," with January often seeing the highest credit issuance of the year, estimated between 30,000 to 40,000 billion, which can provide additional capital to the market [3]. - The first quarter is also a period of low earnings disclosures for listed companies, favoring investments in technology sectors with potential themes and valuation flexibility [3]. - Analysts suggest that the spring rally may have already begun, with the market continuing its upward trend, and investors are encouraged to maintain confidence and patience [3].

转自：北京日报客户端 2026年A股首个交易日，三大指数放量上涨。 1月5日，上证指数涨1.38%，实现日线12连阳，重返4000点，深证成指涨2.24%，创业板指涨2.85%。全 市场成交额近2.57万亿元，较上一交易日增超5000亿元，超4100个股上涨。 国金证券研报称，在AI强劲需求带动下，2025年存储芯片价格大涨，其中DDR416Gb涨幅达1800%， DDR516Gb涨幅达500%，512Gb NAND闪存涨幅达300%。2026年，全球存储芯片仍将供不应求，有望 持续涨价。 招商证券研报认为，AI需求增长带动全球存储及先进制程产能扩张，展望2026年—2027年，国内存储 及先进制程扩产有望提速，国内设备厂商订单持续向好，份额较高的存储设备公司有望受益。 脑机接口个股上演涨停潮 今日，脑机接口板块大涨，位列同花顺涨幅榜第一，板块内个股掀起涨停潮。其中，倍益康"30CM"涨 停，博拓生物、道氏技术、三博脑科、爱朋医疗等10余只个股"20CM"涨停。 | | | 脑机接口 1 | | | | --- | --- | --- | --- | --- | | | | 1861.12 13.70% | ...

Group 1: Neuralink Developments - Neuralink plans to increase brain-computer interface (BCI) output in 2026, transitioning to nearly fully automated surgeries[3] - As of January 5, 2026, the Wande BCI Index rose by 10.54%, with companies like Sanbo Neuroscience and Meihua Medical hitting the daily limit[3] - Neuralink aims to exceed 25,000 electrodes by 2028, expanding applications to treat mental disorders and integrating with AI[3] Group 2: Policy and Market Support - Multiple government departments in China are supporting BCI development, with the National Healthcare Security Administration including BCI in medical insurance as of March 2025[3] - The "14th Five-Year Plan" lists BCI as one of the six future industries, aiming for significant breakthroughs by 2027[3] - As of December 2025, the BCI sector in China has seen 24 financing rounds, totaling over 5 billion yuan, with a record single financing of 350 million yuan[3] Group 3: Clinical and Commercial Progress - Domestic BCI projects are moving from exploration to clinical stages, with significant trials completed in 2025[3] - The first long-term invasive BCI clinical trial in China was completed in March 2025, marking a milestone in the field[3] - Companies like Sanbo Neuroscience and Meihua Medical are highlighted as key players in the BCI industry, with potential for accelerated commercialization[3]

Market Overview - The Hong Kong stock market experienced fluctuations, with the Hang Seng Index closing up 0.03% at 26,347.24 points and a total trading volume of HKD 283.46 billion [1] - The Hang Seng Tech Index rose by 0.09%, while the Hang Seng China Enterprises Index fell by 0.22% [1] Blue-Chip Stocks Performance - Kuaishou-W (01024) led blue-chip stocks, surging 11.09% to HKD 73.6, contributing 35.65 points to the Hang Seng Index [2] - Other notable performers included Innovent Biologics (01801) up 6.09% and Chow Tai Fook (01929) up 5.13% [2] - Conversely, China National Petroleum (00857) and Wharf Real Estate (01997) saw declines of 3.52% and 3.57%, respectively, negatively impacting the index [2] Sector Highlights Technology Sector - Major tech stocks mostly rose, with Kuaishou increasing by 11% and Alibaba by over 2% [3] - The brain-computer interface concept gained traction following Elon Musk's announcement of large-scale production plans for Neuralink in 2026 [4] Real Estate Sector - The real estate sector showed strong performance, with Greentown China (03900) rising 6.56% and Shimao Group (00813) up 5.76% [4] - An article in "Qiushi" magazine emphasized the importance of stabilizing market expectations in the real estate sector, suggesting proactive measures to shorten adjustment periods [4] Pharmaceutical Sector - Pharmaceutical stocks performed robustly, with Zhaoyan New Drug (06127) up 13.73% and Yimeng Biotech (09606) up 11.81% [5] - The National Medical Products Administration reported a record number of approved innovative drugs in 2025, significantly exceeding previous years [5] Insurance Sector - Insurance stocks collectively rose, with New China Life (01336) increasing by 5.34% and China Life (02628) by 3.4% [6] - The insurance industry reported a 7.6% year-on-year growth in premium income for the first 11 months of 2025 [6] Automotive Sector - Automotive stocks faced declines, with Great Wall Motors (02333) down 6.15% and XPeng Motors (09868) down 4.6% [6] - The 2026 vehicle trade-in subsidy policy will continue, with adjustments to subsidy amounts based on vehicle pricing [7] Oil Sector - Oil stocks were generally weak, with China National Petroleum (00857) down 3.52% [7] - The geopolitical situation in Venezuela may impact oil prices, with potential increases in production posing risks for future pricing [7] Notable Stock Movements - Woan Robotics (06600) reached a new high, closing up 19.57% at HKD 110, with plans to launch a humanoid home robot in January 2026 [8] - Black Sesame Technologies (02533) rose 11.21% after announcing its high-performance smart driving chip received approval for global sales [9]

市场全天震荡走强，沪指重返4000点上方，创业板指涨近3%。脑机接口概念掀涨停潮，三博脑科、创新医疗等20余股涨停。半导体板块走强，存储芯片方 向领涨，恒烁股份、兆易创新等涨停。AI应用方向拉升，当虹科技、蓝色光标等涨停。保险板块走强，新华保险、中国太保均涨超7%，股价齐创历史新 高。个股涨多跌少，沪深京三市超4100股飘红，今日成交2.57万亿。 二、当日热点 1.脑科学 一、行情回顾 脑科学板块今日掀起涨停潮，三博脑科、美好医疗、岩山科技、创新医疗等多股一字涨停。 催化上，2025年12月31日，马斯克在社交媒体宣布，其脑机接口公司"神经连接"将于2026年启动脑机接口设备"大规模生产"，并采用更精简的自动化外科手 术流程，电极丝可直接穿过硬脑膜无需切除，目前全球已有12人植入该设备，累计使用时长超1.5万小时。 此外，据智通财经报道，1月4日，上海黄浦区印发相关措施，鼓励脑机接口企业申报国家及市级重点项目，给予最高200万元区级配套支持，同时对脑信号 传感元件、脑机芯片等关键技术攻关按项目总投资30%给予最高200万元扶持。 | 股票名称 | 最新价 = | 涨跌幅 = | 涨停时间 = | 换手率 = ...

1月5日，A股市场高开高走迎来2026年开门红，创业板指领涨，沪指重回4000点上方，录得十二连阳。 板块层面，商业航天概念反复活跃，雷科防务（002413）4连板，中国卫通（601698）5天3板，当虹科 技、谱尼测试（300887）、云汉芯城（301563）、西测测试（301306）等多股20CM涨停，海格通信 （002465）、银河电子（002519）、高德红外（002414）、北斗星通（002151）等20股涨停。 消息面上，据央视新闻报道，中国航天的新蓝图正在展开。载人登月项目将展开多项试验，嫦娥七号将 奔赴月球南极寻找水冰存在的证据，多型新火箭将首飞并挑战回收。中国航天正朝着建设航天强国的目 标开启新的征程。 开源证券研究所指出：SpaceX、天兵科技等国内外头部商业航天企业均计划于2026年推进IPO进程。在 政策支持与产业发展的双重共振下，商业航天领域已成为资本市场瞩目的新热点。 开源证券认为，脑机接口将定义人形机器人的人机交互新范式，探索人脑作为机器人大脑可能性，构建 人机融合的终极生态。近期脑机接口利好不断，印证了脑机接口技术预计将在2026年迈向商业化，并从 医疗刚需向AI应用、机器人等 ...

Market Overview - On the first trading day of 2026, the three major indices in A-shares experienced significant gains, with the Shanghai Composite Index rising by 1.38% and returning to the 4000-point mark, while the Shenzhen Component Index and the ChiNext Index increased by 2.24% and 2.85% respectively. The total market turnover reached approximately 2.57 trillion yuan, an increase of over 500 billion yuan compared to the previous trading day, with more than 4100 stocks rising [1]. Sector Performance - The storage chip sector showed strong performance, with leading stock Zhaoyi Innovation seeing a net inflow of 2.046 billion yuan, ranking first in A-shares and being the only stock with net inflow exceeding 2 billion yuan. Zhaoyi Innovation's stock price hit the daily limit, closing at 235.68 yuan per share, with a total market capitalization of 157.4 billion yuan. The stock price increased by 101.17% in 2025 [3][4]. - Other stocks in the storage chip sector, such as Hengsuo Co., Yunhan Chip City, and Puran Co., also reached their daily limit, indicating a strong upward trend in this sector [5]. Future Outlook - According to research from Guojin Securities, the demand for AI is expected to drive significant price increases in storage chips, with DDR4 16Gb prices projected to rise by 1800%, DDR5 16Gb by 500%, and 512Gb NAND flash by 300% by 2025. The global demand for storage chips is anticipated to continue exceeding supply in 2026, leading to sustained price increases [9]. - Research from招商证券 suggests that the growth in AI demand will drive the expansion of global storage and advanced process capacities, with domestic storage and advanced process expansions expected to accelerate from 2026 to 2027, benefiting domestic equipment manufacturers with strong order flows [9]. Brain-Computer Interface Sector - The brain-computer interface sector experienced a surge, with stocks like Beiyikang and Botao Bio reaching their daily limits. The sector was the top performer on the Tonghuashun gainers list, with over ten stocks hitting the daily limit [11]. - The announcement by Elon Musk regarding Neuralink's plans to start large-scale production of brain-computer interface devices in 2026, along with nearly fully automated surgical procedures, marks a significant milestone for the sector, transitioning brain-computer interfaces from experimental tools to widely available products [11].

Group 1 - The A-share market opened positively in 2026, with the ChiNext Index leading the gains and the Shanghai Composite Index surpassing 4000 points, marking a twelve-day winning streak [1] - The commercial aerospace sector is experiencing significant activity, with multiple stocks hitting the daily limit up, including Leike Defense and China Satellite Communications [1] - China's space exploration initiatives are advancing, with plans for manned lunar missions and the Chang'e 7 mission aimed at finding water ice on the Moon [1] Group 2 - The brain-computer interface (BCI) sector is witnessing a surge, with individual stocks like Beiyikang hitting the daily limit up, reflecting a broader market trend [2] - Elon Musk's company Neuralink plans to begin large-scale production of BCI devices in 2026, which could revolutionize human-robot interaction and expand applications beyond medical needs [2] - The global BCI market is projected to grow to approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034 [2] Group 3 - Goldman Sachs recommends overweighting Chinese stocks in 2026, predicting annual market growth of 15% to 20% for 2026 and 2027, driven by factors such as AI applications and the "going out" trend [2] - The current valuation of the Chinese stock market is significantly discounted compared to global peers, presenting potential investment opportunities [2]

Market Overview - A-shares opened positively on January 5, with major indices rising significantly; the Shanghai Composite Index returned above 4000 points, closing up 1.38%, the Shenzhen Component Index up 2.24%, and the ChiNext Index up 2.85% [2] Stock Performance - A total of 4185 stocks rose, with 127 hitting the daily limit, while 1168 stocks declined [3] - Brain-computer interface stocks surged, with companies like Sanbo Brain Science and Innovation Medical hitting the daily limit; this was driven by Elon Musk's announcement that Neuralink plans to start large-scale production of brain-computer interface devices in 2026 [3] - The semiconductor sector also performed well, particularly in memory chips, with companies like Hengsuo and Zhaoyi Innovation hitting the daily limit [3] - AI application stocks saw gains, with firms such as Anhui Technology and BlueFocus hitting the daily limit [4] - The insurance sector strengthened, with New China Life and China Pacific Insurance both rising over 7%, reaching historical highs [5] Regional Market Trends - In the Asia-Pacific market, Japan's Nikkei 225 index surged nearly 3% on the first trading day of 2026, while the TOPIX index rose 2.12%, reaching a historical high [5] - The KOSPI index in South Korea continued its upward trend, increasing by 3.15% to a new historical high of 4448.52 points, driven by a more than 7% rise in Samsung Electronics' stock [5] Geopolitical Impact - A large-scale military operation by the U.S. against Venezuela led to a spike in gold and silver prices, while oil prices experienced volatility due to global supply concerns [6] - Analysts noted that geopolitical tensions often dissipate quickly, and the recent escalation in Venezuela did not significantly impact global risk assets, indicating a tendency for markets to quickly digest such shocks [6]